Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

1612608

USP

Silver sulfadiazine

United States Pharmacopeia (USP) Reference Standard

Synonyme(s) :

Silver(I) sulfadiazine, Sulfadiazine silver

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C10H9AgN4O2S
Numéro CAS:
22199-08-2
Poids moléculaire :
357.14
Numéro MDL:
MFCD00072101
Code UNSPSC :
41116107
ID de substance PubChem :
329751096
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

sulfadiazine

Fabricant/nom de marque

USP

Pf

285 °C (dec.) (lit.)

Application(s)

pharmaceutical (small molecule)

Format

neat

Chaîne SMILES 

Nc1ccc(cc1)S(=O)(=O)N([Ag])c2ncccn2

InChI

1S/C10H9N4O2S.Ag/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1

Clé InChI

UEJSSZHHYBHCEL-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Silver sulfadiazine USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Silver Sulfadiazine Cream

Remarque sur l'analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

1625009

Sulfadiazine, United States Pharmacopeia (USP) Reference Standard

1633506

Sulfanilic acid, United States Pharmacopeia (USP) Reference Standard

PHR1343

Sulfadiazine, Pharmaceutical Secondary Standard; Certified Reference Material

S1800000

Sulfadiazine, European Pharmacopoeia (EP) Reference Standard

Y0001469

Sulfadiazine impurity A, European Pharmacopoeia (EP) Reference Standard

Y0001480

Sulfadiazine, European Pharmacopoeia (EP) Reference Standard

Y0001462

Acetylsulfadiazine, European Pharmacopoeia (EP) Reference Standard

PHR1419

Sulfanilic Acid, Pharmaceutical Secondary Standard; Certified Reference Material

BP312

Sulfadiazine, British Pharmacopoeia (BP) Reference Standard

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

F W Fuller et al.
The Journal of burn care & rehabilitation, 15(3), 213-223 (1994-05-01)
A review of the periodical literature relating to burn topical antibacterial agents as listed in the Cumulated Index Medicus from January 1, 1965, through November 30, 1992, as well as bound volumes and unpublished material reveals that the optimal dose
Diagnostic challenges of assessing the depth of burn injuries overlying intricate coloured tattoos.
U Sarwar et al.
Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 67(7), e186-e187 (2014-02-25)
Myth: silver sulfadiazine is the best treatment for minor burns.
J Y Chung et al.
The Western journal of medicine, 175(3), 205-206 (2001-08-31)
M Prosdocimi et al.
Minerva medica, 103(6), 533-539 (2012-12-12)
Diabetes-related chronic cutaneous lesions are a serious and common problem, as well as a major cause for hospital admissions, although no general consensus has been reached on the best available treatment for this frequent pathological condition. The primary objective of
Frederick W Fuller
Journal of burn care & research : official publication of the American Burn Association, 30(3), 464-470 (2009-04-08)
Silver sulfadiazine cream has an enviable safety record in burn treatment. However, it side effects, exemplified by allergic reactions to its sulfadiazine moiety, silver staining of the treated burn wound, hyperosmolality, methemoglobinemia, and hemolysis due to a congential lack of
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique